Levels or activity of DIP-related pathways may be altered during periods of chronic stress, sleep disruption, aging, or neurological imbalance
Understanding these mechanisms and effects provides important context when evaluating any potential safety concerns, including questions about cardiovascular risks such as blood clots
The drugs are meant for continuing use, so "we really need to think about the long-term safety and effectiveness of these medications for this population," she said
The landscape of medical weight loss has fundamentally changed
The high-dose arm at 9 mg produced the 20% reduction
Semaglutide, a leading GLP-1 receptor agonist, demonstrated a mean weight loss of 14.9% at weekly doses of 2.4 mg, compared with only 2.4% for placebo